Global Medicines Leader
Dr. Kirk is a global medicines leader in the oncology global medicines development function at AstraZeneca. He is responsible for the cross-functional leadership, project management, development and delivery of new oncology products to market, and has responsibility for programs that encompass pivotal phase III trials in lung cancer, thyroid cancer and pediatric oncology.
Dr. Kirk has been at AstraZeneca for 21 years and has spent the last 11 years in project management roles. He previously served as a team manager in pharmaceutical development.